Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Citius Oncology, Inc. (CTOR) Free Cash Flow per Share data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
Income Statement Financials | |
-- |
|
$-7.74M |
|
-- |
|
-- |
|
$7.47M |
|
$-7.47M |
|
-- |
|
$-7.47M |
|
$-7.47M |
|
$-7.74M |
|
$-7.74M |
|
$-7.74M |
|
$-7.74M |
|
$-7.47M |
|
$-7.47M |
|
71.55M |
|
71.55M |
|
$-0.11 |
|
$-0.11 |
|
Balance Sheet Financials | |
$18.04M |
|
-- |
|
$73.40M |
|
$91.44M |
|
$49.74M |
|
$3.80M |
|
$6.06M |
|
$55.80M |
|
$35.64M |
|
$35.64M |
|
$35.64M |
|
71.55M |
|
Cash Flow Statement Financials | |
$0.00M |
|
-- |
|
-- |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
$3.90M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
0.36 |
|
-- |
|
-- |
|
0.10 |
|
0.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-21.70% |
|
-21.70% |
|
-8.46% |
|
-19.61% |
|
$0.50 |
|
Free Cash Flow per Share |
-- |
-- |